西山科技 (688576)
Chongqing Xishan Science and Technology Co., Ltd.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 4550.01
- Circulating A-Shares(W): 2179.22
- Earnings Per Share(RMB): 0.9600
- Net Assets Per Share(RMB): 37.7648
- Operating Revenue(W RMB): 23080.06
- Total Profit(W RMB): 4425.72
- **Net Profit Attributable to Parent(W RMB) **: 4339.50
- Net Profit Growth Rate(%): -34.14
- Weighted Return on Equity(%): 2.5100
- Operating Cash Flow Per Share(RMB): 1.1240
- Undistributed Profit Per Share(RMB): 4.8378
- Capital Reserve Per Share(RMB): 31.9613
2. Main Business
The main business covers:
- Research, development, production, and sales of surgical power devices
3. Company Basic Information
- Company Name: Chongqing Xishan Technology Co., Ltd.
- Listing Date: 2023-06-06
- Industry: Pharmaceuticals & Healthcare - Medical Devices
- Address: Jupiter Technology Development Center, High-tech Park, Northern New Area, Chongqing (No. 9, Middle Section of Huangshan Avenue)
- Website: https://www.xishantech.com.cn
- Company Profile: The company was established through the overall transformation of Xishan Co., Ltd. On July 16, 2015, Xishan Co., Ltd. held an interim shareholders' meeting and agreed to use May 31, 2015 as the restructuring base date to transform the company into a joint stock limited company. The registered capital of the joint stock company was 10 million yuan, based on the net assets of Xishan Co., Ltd. as of May 31, 2015, which were 34.4504 million yuan as confirmed by the audit report issued by Sichuan Huaxin (Group) Accounting Firm (Special General Partnership). The net assets were converted into 10 million shares at a ratio of 3.445:1, and the excess portion of the net assets, 24.4504 million yuan, was included in the capital reserve. On July 31, 2015, the company held its founding meeting and agreed to establish Xishan Technology. In August 2015, the establishment of the joint stock company was registered with the Chongqing Administration for Industry and Commerce, and a new business license was obtained.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | China Pharmaceutical Investment Co., Ltd. | General Legal Person | 194.78 | 8.94 |
| 2 | Suzhou Jinhe Phase II Equity Investment Partnership (Limited Partnership) | General Legal Person | 142.90 | 6.56 |
| 3 | Shanghai Hongfu Private Fund Management Co., Ltd. - Fujian Songde Equity Investment Partnership (Limited Partnership) | General Legal Person | 120.43 | 5.53 |
| 4 | Chongqing Liangjiang New Area Chengqian Venture Investment Fund Partnership (Limited Partnership) | General Legal Person | 31.61 | 1.45 |
| 5 | Dacheng Jingheng Hybrid Securities Investment Fund Class A | Fund | 30.20 | 1.39 |
| 6 | Chongqing Zhongcheng No. 3 Enterprise Management Center (Limited Partnership) | General Legal Person | 29.90 | 1.37 |
| 7 | Chongqing Zhongcheng No. 4 Enterprise Management Center (Limited Partnership) | General Legal Person | 23.90 | 1.10 |
| 8 | Chongqing Zhongcheng No. 2 Enterprise Management Center (Limited Partnership) | General Legal Person | 19.60 | 0.90 |
5. Concept Sectors
- Margin Trading & Securities Lending
- High-Performance Stocks
- Below IPO Price
- Specialized, Refined, Unique, and Innovative Enterprises
- Micro and Small Cap Stocks
Remarks
- Data update date: 2025-11-10
- Data source: Public Market Information